46 results
8-K
EX-3.1
UNCY
Unicycive Therapeutics Inc
14 Mar 24
Unicycive Announces $50 Million Private Placement
4:28pm
into or exchanged for shares of capital stock that represent, immediately following such merger or consolidation, at least a majority, by voting power … stockholders first approve the Proposal.
“Requisite Holders” means Holders of a majority of the then outstanding shares of Series B Preferred Stock
8-K
EX-10.1
nnt2s4zt8f oi
14 Mar 24
Unicycive Announces $50 Million Private Placement
4:28pm
8-K
EX-4.2
367taggqpx7nfq5
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-4.1
0dlgbg
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-4.3
9cvif8hvw1r
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
8-K
EX-3.6
58t tz1tvm
14 Mar 24
Entry into a Material Definitive Agreement
4:00pm
PRE 14A
nv0x xxurpo36
18 Apr 23
Preliminary proxy
5:25pm
S-3
EX-4.3
gv6cywsx00ngd0h2
15 Aug 22
Shelf registration
6:20pm
S-3
vxygkcl7utr n8p294gi
15 Aug 22
Shelf registration
6:20pm
S-3
EX-4.4
iinkmlx245hco59
15 Aug 22
Shelf registration
6:20pm
DEF 14A
bhl84lho12sp
19 Apr 22
Definitive proxy
4:00pm
10-K
pyc cgcqs
31 Mar 22
Annual report
6:18am